Sir, Is retinopathy of prematurity seasonal? Implications for screening and treatment Retinopathy of prematurity (ROP) is a potentially avoidable cause of childhood blindness, the stages of which have been defined by the International Classification of Retinopathy of Prematurity. 1 In the United Kingdom, screening of at-risk babies (birth weight o1500 g or o32 weeks gestational age) occurs until vascularization is complete, or until disease progression mandates treatment. 2, 3 It has been shown internationally that infants with different characteristics can develop severe ROP, associated with the level of the country's development, emphasizing that ROP screening programmes need to be appropriate for the local population. 4 In light of this, we wished to evaluate if a pattern existed for ROP screening and treatment for our population, which could be affected by NHS work patterns.
It is commonly recognized that there is a steady monthly increase in the general population birth rate from January, with a peak in August and then a gradual decline to December. This has also been the pattern in Glasgow. We reviewed our theatre logbook and identified 129 ROP laser procedures from 1994 to 2010. In this time period we discovered a peak of treatment in September, with a lesser peak in February and June. This pattern was mirrored by the average screening events in the past 2 years (see Figure 1 ). This seasonal pattern of ROP has not been described before with reference to the NHS workforce, with peaks around the times of widespread junior doctor changeover in all specialties at the start of August and February.
This seasonal trend may have implications for service provision and maintaining safe continuity of care at times of junior staff turnover (for referral and communication) and senior staff leave (for service delivery). Severe ROP requiring treatment is infrequent in the United Kingdom, yet this treatment is specialized, and should be performed by ophthalmologists with appropriate training and competence. It is the view of the Guideline Development Group for ROP that once identified, treatment should occur within 48 h. 3 Clinicians providing ROP treatment should be aware that their workload will have seasonal variation, with peak times of service delivery for their population, and plan accordingly.
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The authors declare no conflict of interest. Ghosh et al. 1 present three cases of inadvertent trypan blue injection into the subretinal space and suggest an alternative safer method of injection into the vitreous cavity using a backflush flute.
Low-viscosity substances such as stains, triamcinolone, and heavy liquids are commonly used during vitrectomy surgery. We would like to suggest an alternative method of injecting any of these substancesFthat of injection through the vitrectomy probe itself.
A three-way tap is inserted into the distal split point in the aspiration tubing of the vitrectomy probe and a syringe containing the low-viscosity substance is attached (Figure 1) . To allow injection, the three-way tap 
www.nature.com/eye CORRESPONDENCE is turned to close off the aspiration line to the vitrectomy pump and the substance injected via an assistant, with the surgeon directing the port of the probe to the desired location. After injection, the three-way tap is again turned off to the line, allowing active aspiration from the eye.
The advantages of the system are that the injection is directed through the side port of the probe and hence not directly towards the retina, thus reducing the risk of subretinal injection. Furthermore, the injection can be directed to the area of interest, for example, peripheral membranes. There is no need to enter and exit the eye for injection or aspiration of the injected substance, thus reducing potential retinal tear formation and pathogen entry into the eye.
A couple of points regarding the technique are worth observing. There is some dead space between the injection point on the three-way tap and the cutter port. With the set-up we have used this is B0.45 ml. This volume is irrelevant in terms of heavy liquids and diluted triamcinolone, but is more significant with low-volume membrane stains. We have, however, found that there is sufficient volume in the stains we have used to provide adequate staining. It is also important for the three-way tap to be primed with the infusion solution at the start of the case to avoid air injection during injection, which is important when injecting into a fluid-filled eye.
In conclusion, this is a simple and safe technique that reduces instrument exchange and improves surgical flow.
